Trial Profile
Sofosbuvir and simeprevir for patients with genotype-1 Hepatitis C, post-liver transplant.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2015 New trial record